RZLT — Rezolute Inc

Founder-Led

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Rezolute Inc

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$3.32
Market Cap$310M
Float66.0M
Shares Outstanding96.3M
vs. Analyst Target+77.0% to analyst PT
Dividend RateNone
Analyst Target Price$5.88 (10 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 N/A -$20.3M -$18,000 -$20.3M
2021 N/A -$20.9M -$13,000 -$20.5M
2022 N/A -$41.1M -$256,000 -$39.2M
2023 N/A -$51.8M -$382,000 -$56.0M
2024 N/A -$68.5M -$36,000 -$70.4M
2025 N/A -$74.4M -$31,000 -$79.9M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $46,000 -$24.4M
Sep 2025 N/A -$18.1M
Dec 2025 N/A -$22.8M
Mar 2026 N/A -$16.2M

Ownership & Float

Insider Ownership10.2%
Institutional Ownership90.3%
Short Float20.8%
% of All Funds Holding1.40%
Number of Funds Holding115

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$3.27Near-term / short-term trend
Weekly40-Week SMA$5.25Medium-term trend
Weekly80-Week SMA$4.89Cyclical trend (business cycle)
Weekly200-Week SMA$3.44Secular trend (multi-year)
Monthly10-Month SMA$5.40Near-term monthly trend
Monthly20-Month SMA$5.02Medium-term monthly trend
Monthly40-Month SMA$3.72Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$2.40 support 1.44x 3 months ago
$9.50 resistance 5.77x 4 months ago
$1.70 support 2.05x 25 months ago

Historical Earnings Reactions (47 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.47% 0.00% 42.55% 23.08% -49.64%
1 Day -0.59% 0.00% 34.04% 29.63% -39.29%
1 Week -1.81% -4.17% 36.17% 62.16% -53.57%
2 Weeks 0.33% -4.47% 36.96% 91.01% -49.26%
1 Month -3.28% -8.77% 32.61% 118.18% -52.01%

Next earnings: July 31, 2026 (63 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan24.3%69.2%13
Feb-4.3%35.7%14
Mar-8.2%21.4%14
Apr1.5%57.1%14
May2.3%46.2%13
Jun8.7%61.5%13
Jul17.8%38.5%13
Aug-0.3%46.2%13
Sep-2.9%30.8%13
Oct-14.6%15.4%13
Nov2.0%38.5%13
Dec-10.8%23.1%13

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.38% 32.6% 629
Tuesday -0.07% 31.3% 694
Wednesday 0.09% 36.3% 688
Thursday 0.56% 34.1% 675
Friday 0.67% 38.6% 674

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 90.3%

Insider Transactions — Smart Summary

Total insider ownership: 10.2%

Founder-led management: Nevan Charles Elam (Founder, CEO, Principal Financial Officer & Acting Chairman of the Board)

12-Month Insider Activity Summary

Total Filings10
Net Value+$257,344.87
Net Shares Change1,374,095
% of Float2.1%
C-Suite Filings7
Clusters Detected2

Key Insiders

NameTitleNet ValueFilingsActivity
Kim Young-Jin +$4.0M 1 1 buy
Evans Daron CFO +$128,327.5 3 4 buy
ROBERTS BRIAN KENNETH Chief Medical Officer +$58,539 2 2 buy
Elam Nevan C CEO +$50,880 1 1 buy
Karnawat Sunil Ratilal Chief Commercial Officer +$19,598.37 1 1 buy
KREHER NERISSA +$9,997 1 1 buy
Hogenhuis Wladimir +$9,548.5 1 1 buy

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-06-19 – 2025-06-25 4 4 +$4.0M 2 C-suite
2025-12-15 – 2025-12-17 5 5 +$207,204.37 4 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-03-31 Evans Daron CFO +$28,500 Transaction at $2.85, now +16.5%
2025-12-15 Evans Daron CFO +$79,577.5 Transaction at $1.78, now +86.9%
2025-12-15 Karnawat Sunil Ratilal Chief Commercial Officer +$19,598.37 Transaction at $1.62, now +105.0%
2025-12-17 ROBERTS BRIAN KENNETH Chief Medical Officer +$47,600 Transaction at $1.70, now +95.3%
2025-12-15 Elam Nevan C CEO +$50,880 Transaction at $1.59, now +108.8%
2025-12-17 Hogenhuis Wladimir +$9,548.5 Transaction at $1.69, now +96.4%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Rezolute Inc (RZLT) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for RZLT on Trend Edge →